https://www.zacks.com/stock/news/2300824/wall-street-analysts-see-a-57-38-upside-in-lifestance-health-lfst-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2300824
Jul 12, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 57.4% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:-4713980453902559605
0
https://www.zacks.com/stock/news/2300823/wall-street-analysts-see-a-29-08-upside-in-matador-mtdr-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2300823
Jul 12, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 29.1% in Matador (MTDR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:965134351619180497
0
https://www.sandiegouniontribune.com/2024/07/11/to-find-californias-biggest-rent-hikes-see-whos-hiring/
Jul 11, 2024 - Counties with employment gains averaged 3.8% rent increases vs. 3.1% where jobs fell.
0
sgt:-5057765320993041814
0
https://www.zacks.com/stock/news/2299895/wall-street-analysts-see-gray-television-gtn-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2299895
Jul 11, 2024 - The average brokerage recommendation (ABR) for Gray Television (GTN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
zc:-1901204281869262017
0
https://www.cnbc.com/2024/07/10/ethereum-etf-countdown-bitwise-cio-sees-birth-of-a-new-asset-class.html
Jul 10, 2024 - Spot ether ETFs could hit the market as soon as this week, pending SEC approval, and Bitwise’s chief investment officer plans to get in on the action.
0
cnbc:-1716141417090553326
0
https://www.rttnews.com/story.aspx?Id=3459149
Jul 10, 2024 - After moving mostly higher early in the session, stocks have seen further upside over the course of the trading day on Wednesday. The major averages have all climbed firmly into positive territory, with the S&P 500 breaking above 5,600 for the first time ever.
0
rttnews:-8931735804850561511
0
https://www.zacks.com/stock/news/2299242/wall-street-analysts-see-a-45-41-upside-in-amplify-energy-ampy-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2299242
Jul 10, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 45.4% in Amplify Energy (AMPY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:-3687422415427950820
0
https://www.rttnews.com/story.aspx?Id=3459094
Jul 10, 2024 - After ending yesterday's choppy trading session little changed, stocks are likely to move mostly higher in early trading on Wednesday. The major index futures are currently pointing to initial strength on Wall Street, with the S&P 500 futures up by 0.3 percent.
0
rttnews:-8931736804867561542
0
https://www.zacks.com/stock/news/2298759/powell-sees-cooling-economy-traders-see-coming-rate-cut?cid=CS-ZC-FT-ahead_of_wall_street-2298759
Jul 09, 2024 - It's doubtful big market moves will happen before big inflation data comes out later this week.
zc:-7022693393561244861
0
https://seekingalpha.com/news/4123073-bmo-sees-bmrn-legn-sln-as-attractive-ma-targets?source=feed_sector_healthcare
Jul 09, 2024 - BMO Capital said it views BioMarin (BMRN), Legend (LEGN) and Silence Therapeutics (SLN) as attractive M&A targets following Eli Lilly’s (LLY) deal with Morphic. Read more here.
0
sa:-3374828079622297398
0